Reconciliation of recent western and eastern consensus on treatment of Helicobacter pylori eradication
Helicobacter pylori(H.pylori)is a major pathogenic factor for gastric cancer and an important pathogenic factor for gastrointestinal disease and affects other human systems.In order to regulate the treatment of H.pylori and re-duce the incidence of gastric cancer,western and eastern consensus is constantly updated.In 2022,both China and Eu-rope released the latest consensus reports on H.pylori management,namely ″2022 Chinese national clinical practice guideline on Helicobacter pylori eradication treatment″ and ″Management of Helicobacter pylori infection:the Maastricht Ⅵ/Florence consensus report″.In this paper,the above guidelines would be reviewed and compared from six aspects:antibiotic management,eradication program,eradication process,eradication course,enhancement of acid inhibition and other adjuvant drugs,so as to provide reference for standardized clinical eradication of H.pylori therapy.
NETL
NSTL
万方数据
